Alcon launches AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens.
Alcon, the global leader in eye care and a division of Novartis, announces the launch of AcrySof IQ PanOptix Toric presbyopia- and astigmatism-correcting intraocular lens (IOL) for patients with pre-existing corneal astigmatism undergoing cataract surgery. It is a new option for astigmatic patients who seek to address their near, intermediate and distance vision needs with a single lens.
The product received CE Mark on 15 June 2015.
"Today's patients undergoing cataract surgery are more likely to seek vision correction options to address various lifestyle tasks such as reading books, using electronic tablets, working on computers and performing outdoor activities without the need for glasses or contact lenses," said Richard Packard, MD, FRCS, FRCOphth, Director and senior ophthalmologist, Arnott Eye Associates, London, United Kingdom. "The AcrySof IQ PanOptix trifocal IOL is an important option that should provide these patients with a full range of vision and thus significantly reduced dependence on glasses.".
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins